WO2010145922A2 - Compositions anti-transpirantes contenant du citrate d'argent - Google Patents

Compositions anti-transpirantes contenant du citrate d'argent Download PDF

Info

Publication number
WO2010145922A2
WO2010145922A2 PCT/EP2010/057210 EP2010057210W WO2010145922A2 WO 2010145922 A2 WO2010145922 A2 WO 2010145922A2 EP 2010057210 W EP2010057210 W EP 2010057210W WO 2010145922 A2 WO2010145922 A2 WO 2010145922A2
Authority
WO
WIPO (PCT)
Prior art keywords
weight
aluminum
water
preferred
preparation according
Prior art date
Application number
PCT/EP2010/057210
Other languages
German (de)
English (en)
Other versions
WO2010145922A3 (fr
Inventor
Bernhard Banowski
Imme Breuer
Barbara Heide
Gertraud Teckenbrock
Bernd Anderheggen
Original Assignee
Henkel Ag & Co. Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Ag & Co. Kgaa filed Critical Henkel Ag & Co. Kgaa
Publication of WO2010145922A2 publication Critical patent/WO2010145922A2/fr
Publication of WO2010145922A3 publication Critical patent/WO2010145922A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/0279—Porous; Hollow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A61K2800/31—Anhydrous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/651—The particulate/core comprising inorganic material

Definitions

  • the invention describes antiperspirant anhydrous cosmetic or dermatological preparations comprising water-soluble silver citrate-citric acid complexes in combination with passivating agents selected from the group of silicic acids.
  • aqueous colloidal silver solutions are either liquid dispersions of elemental silver or liquid dispersions of complex sparingly soluble silver compounds.
  • the water-dispersible starting materials then contain silver ions only in traces.
  • WO 2006029213 A1 describes antimicrobial silver citrate compounds. These stabilized in aqueous citric acid silver compounds are commercially available under TINOSAN ® SDC. The preparation of these compounds via an electrochemical process is described in EP 1 041 879 A1.
  • TINOSAN ® SDC contains electrolytically generated silver ions (Ag + ) and there is no colloidal silver in the mixture.
  • TINOSAN described in the publications WO 2006029213 A1 and EP 1041879 A1 ® SDC may be used in cosmetic, in aqueous and / or emulsion based composition and with various additives.
  • deodorants and antiperspirants in combination with TINOSAN ® SDC in WO 2006029213 A1 describes.
  • the use of silver compounds dissolved in water due to corrosion in metallic storage media, such as, for example, aerosol cans presents a problem. This effect is enhanced by the presence of corrosion promoting compounds such as aluminum and / or aluminum / zirconium antiperspirant salts.
  • DE 202008014407 U1 proposes to solve these problems using one or more passivating agents selected from the group of phyllosilicates and / or talc.
  • means may be provided, which may contain up to 10 wt .-% water (wt .-% of other sources than 5% by weight of the TINOSAN ® SDC plus additional 5).
  • water-soluble silver compounds stably in cosmetic compositions, even if the water contents are well below 10 wt .-%. Even in systems with much less water, it should be possible to administer antimicrobial silver compounds dissolved in water from an actually water-hostile environment.
  • anhydrous cosmetic or dermatological preparation comprising silver citrate-citric acid complexes having a water content of up to 90% by weight, based on the total mass of the complex, in combination with one or more passivating agents selected from the group of silicic acids. Furthermore, one or more antiperspirant active ingredients and perfume are preferably contained in the preparation.
  • Anhydrous preparation according to the invention means that in addition to the water contained in the silver complex, up to 90 wt .-% with respect to the total complex mass, only additional water up to a proportion of about 6 wt .-%, based on the total mass of the preparation can be.
  • Anhydrous is preferably a proportion of not more than 2 wt .-%, in particular 0 wt .-%, based on the total mass of the preparation.
  • the preparation therefore contains a maximum of 3% by weight of further water, based on the total mass of the preparation. In a preferred maximum proportion of silver citrate complex of about 5 wt .-% and contained therein water of max.
  • the preparation according to the invention preferably comprises a maximum of 4-5% by weight of water which can be introduced through the complex.
  • at most 3% by weight of further water is accepted in the formulation without causing problems as known in the art.
  • a maximum water content of 8% by weight, formed from water from the complex and water from other preparation constituents or extra added water, can therefore be contained in the preparation as a whole according to the invention without any loss in the below-described advantages of the preparation according to the invention comes.
  • the preparation according to the invention is understood to be anhydrous.
  • the advantages are set out below.
  • the invention makes it possible to use this water-containing silver citrate with its antimicrobial effect in an environment which normally leads to instabilities and storage problems in the presence of water, as stated above.
  • the use of the aqueous silver citrate complex in aerosol formulations would be critical, as the water would damage the metal can or valve parts, e.g. As the spring can corrode.
  • This effect is enhanced by the presence of corrosion promoting compounds, such as aluminum and / or aluminum / zirconium antiperspirant salts, as are common in antiperspirant or deodorant formulations.
  • corrosion promoting compounds such as aluminum and / or aluminum / zirconium antiperspirant salts
  • the water present through the silver citrate complex as well as any additional water (up to 3% by weight), is complexed and bound by the passivating agent.
  • the water supplied through the complex is bound to the passivating agent and is therefore no longer available for damaging influence.
  • the passivating agents are preferably selected from the group of silicas.
  • both hydrophilic silicas and hydrophobic silicas can be used. It is particularly preferred to use mixtures of at least one hydrophilic silica and at least one hydrophobic silica. In this case, it is particularly preferred if the hydrophobic silica (s) is present in excess of the hydrophilic silica (s).
  • Weight ratios are preferably hydrophobic: hydrophilic from 0: 1 to 10: 1, preferably 2: 1 to 6: 1, particularly preferably 3: 1 to 4: 1.
  • Hydrophilic silicas used according to the invention are readily wettable with water.
  • compositions are characterized in that at least one hydrophilic silica in a total amount of 0.2 to 2 wt .-%, preferably 0.4 to 1, 5 wt .-%, particularly preferably 0.5 to 1, 0 Wt .-% and most preferably 0.6 to 0.8 wt .-%, each based on the total weight of the propellant-free composition according to the invention, is included.
  • compositions are characterized in that at least one hydrophilic silica in a total amount of 0.1 to 1 wt .-%, preferably 0.2 to 0.8 wt .-%, particularly preferably 0.3 to 0.5 % By weight, based in each case on the total weight of the composition according to the invention.
  • Hydrophobic silicas used according to the invention are alkyl-modified at least on the surface of the silica particles. They preferably contain hydrophobic groups on the surface, such as (CH 3 ) 3 Si-O-, (-Si (CH 3 ) 2 O-) n ,
  • Preferred hydrophobic silicas are hydrophobic fumed silicas, particularly the alkylated commercial products of Aerosil ® series of Degussa, in particular Aerosil ® -R202, -R805 Aerosil ®, Aerosil ® -R812, -R972 Aerosil ® and Aerosil ® -R976, besides also products the Cab-O-Sil TS series by Cabot, especially Cab-O-Sil TS-530.
  • Particularly preferred hydrophobic silicas are silica silylates and silica dimethyl silylates.
  • Aerosil ® -R972 having a BET surface area of approximately 1 10 rrvYg and about 70% of the surface occupied with methylated hydroxyl groups.
  • Spray compositions preferred according to the invention are characterized in that at least one hydrophobic silica in a total amount of 1-5 wt .-%, preferably 1, 5 - 4 wt .-%, particularly preferably 2 - 3.5 wt .-%, extraordinarily preferably 2.5 to 3 wt .-%, each based on the total weight of the propellant-free composition of the invention is included.
  • compositions are characterized in that at least one hydrophobic silica in a total amount of 0.5 to 5 wt .-%, preferably 0.7 to 4 wt .-%, particularly preferably 0.8 to 3.5 wt. -%, most preferably 1 - 3 wt .-%, each based on the total weight of the composition according to the invention, is contained.
  • compositions according to the invention are characterized in that they contain layer silicate (s) in a total amount of zero to at most 1.3% by weight, preferably zero to at most 1% by weight, more preferably zero to a maximum of 0.5% by weight. %, based on the total weight of the propellant-free composition (sprays) or based on the total weight of the composition (pencil, roll-on, etc.) included.
  • layer silicate s
  • sheet silicates includes in particular talc, soapstone, clay minerals such as montmorillonites, nontronites, hectorites, bentonites, in particular disteardimonium hectorites and quaternium-18 hectorites, saponite, sauconite, beidellite, allevardite, illite, halloysite, attapulgite and sepiolite.
  • clay minerals such as montmorillonites, nontronites, hectorites, bentonites, in particular disteardimonium hectorites and quaternium-18 hectorites, saponite, sauconite, beidellite, allevardite, illite, halloysite, attapulgite and sepiolite.
  • the combination of silver citrate-citric acid complex and silicic acids as passivating agents makes it possible to produce cosmetic or dermatological preparations which develop the desired antimicrobial activity at the site of action only by external addition of water.
  • Cosmetic antiperspirants or deodorants serve to eliminate body odor that results when the odorless fresh sweat is decomposed by microorganisms.
  • the usual cosmetic deodorants are based on different active principles. In that way The antiperspirants (AT) mentioned may be used to reduce sweat formation (antiperspirant) by astringents - predominantly aluminum salts such as aluminum hydroxychloride (aluminum chlorohydrate, ACH or activated ACH - AACH) or aluminum zirconium salts (AZG).
  • the bacterial flora on the skin can be reduced.
  • the odor-causing microorganisms are effectively reduced.
  • the sweat flow itself is not affected, in the ideal case, only the microbial decomposition of the sweat is temporarily stopped.
  • compositions according to the invention contain at least one antiperspirant active substance.
  • Preferred antiperspirant active ingredients are selected from the water-soluble astringent inorganic and organic salts of aluminum, zirconium and zinc or any desired mixtures of these salts.
  • solubility of at least 5 wt .-% at 20 0 C is understood according to the invention, solubility in water, that is, amounts of at least 5 g of the antiperspirant active ingredient in 95 g of water are soluble at 20 0 C.
  • antiperspirant active ingredients are selected from aluminum chlorohydrate, in particular aluminum chlorohydrate having the general formula [Al 2 (OH) 5 Cl. 1-6 H 2 O] n , preferably [Al 2 (OH) 5 Cl. 2-3 H 2 O. ] n , which may be in non-activated or in activated (depolymerized) form, and aluminum chlorohydrate having the general formula [Al 2 (OH) 4 Cl 2 ⁇ 1-6 H 2 O] n , preferably [Al 2 (OH) 4 CI 2 ⁇ 2-3 H 2 O] n , which may be in unactivated or activated (depolymerized) form.
  • aluminum sesquichlorohydrate aluminum dichlorohydrate, aluminum chlorohydrex-propylene glycol (PG) or aluminum chlorohydrex polyethylene glycol (PEG), aluminum or aluminum zirconium glycol complexes, e.g. Aluminum or aluminum zirconium propylene glycol complexes, aluminum sesquichlorohydrex PG or aluminum sesquichlorohydrex PEG, aluminum PG dichlorohydrex or aluminum PEG dichlorohydrex, aluminum hydroxide further selected from the aluminum zirconium chlorohydrates such as aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate, aluminum zirconium octachlorohydrate, aluminum-zirconium chlorohydrate glycine complexes, such as Aluminiumzirco- niumtrichlorohydrexglycin, Aluminiumzirconiumtetrachlorohydrexglycin, Aluminiumzirconium- pentach
  • Antiperspirant active ingredients which are particularly preferred according to the invention are selected from what are known as “activated” aluminum and aluminum zirconium salts, which are also referred to as “enhanced activity” as antiperspirant active ingredients. Such agents are known in the art and are also commercially available. Their preparation is disclosed, for example, in GB 2048229, US 4775528 and US 6010688.
  • Activated aluminum and aluminum-zirconium salts are typically produced by heat-treating a relatively dilute solution of the salt (e.g., about 10% by weight of salt) to increase its HPLC peak 4-to-peak 3 area ratio. The activated salt can then be dried to a powder, in particular spray-dried. In addition to the spray drying z. B. also suitable for drum drying.
  • Activated aluminum and aluminum zirconium salts typically have an HPLC peak 4 to peak 3 area ratio of at least 0.4, preferably at least 0.7, more preferably at least 0.9, with at least 70% of the aluminum attributable to these peaks , Activated aluminum and aluminum zirconium salts do not necessarily have to be used as a spray-dried powder.
  • Antiperspirant active ingredients which are likewise preferred according to the invention are nonaqueous solutions or solubilisates of an activated aluminum or aluminum zirconium antiperspirant salt, for example according to US 6010688, by adding an effective amount of a polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups , preferably propylene glycol, sorbitol and pentaerythritol, are stabilized against the loss of activation against the rapid degradation of the HPLC Peak 4: Peak 3 area ratio of the salt.
  • a polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups preferably propylene glycol, sorbitol and pentaerythritol
  • compositions containing by weight 18-45% by weight of an activated aluminum or aluminum zirconium salt, 55-82% by weight of at least one anhydrous polyhydric alcohol of 3 to 6 carbon atoms and 3 to 6 Hydroxyl groups, preferably propylene glycol, butylene glycol, diethylene glycol, dipropylene glycol, glycerol, sorbitol and pentaerythritol, more preferably propylene glycol.
  • a polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups.
  • Propylene glycol, propylene glycol / sorbitol mixtures and propylene glycol / pentaerythritol mixtures are preferred such alcohols.
  • Such inventively preferred complexes of an activated antiperspirant aluminum or aluminum zirconium salt with a polyhydric alcohol are, for.
  • Further preferred antiperspirant actives are basic calcium aluminate salts, as disclosed, for example, in US Pat. No. 2,577,030. These salts are prepared by reacting calcium carbonate with aluminum chlorhydroxide or aluminum chloride and aluminum powder or by adding calcium chloride dihydrate to aluminum chlorhydroxide.
  • Other preferred antiperspirant actives are aluminum-zirconium complexes as disclosed, for example, in US Pat. No. 4,017,599, which are buffered with salts of amino acids, in particular with alkali metal and alkaline earth glycinates.
  • activated aluminum or aluminum zirconium salts such as disclosed in US 6,245,325 or US 6042816, containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in an amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably 1: 1 to 1:10 and a water-soluble calcium salt in such an amount as to provide Ca: (AI + Zr) weight ratio of 1: 1-1: 28 and preferably 1: 2-1: 25.
  • USP activated aluminum or aluminum zirconium salts
  • an amino acid or hydroxyalkanoic acid in an amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably 1: 1 to 1:10
  • a water-soluble calcium salt in such an amount as to provide Ca: (AI + Zr) weight
  • Particularly preferred solid activated antiperspirant salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum zirconium salt and 1-16% by weight. %, preferably 4-13% by weight molecularly bound water (water of hydration), furthermore sufficient water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25, is and so much amino acid that the amino acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • USP 48-78% by weight
  • % preferably 66-75% by weight of an activated aluminum or aluminum zirconium salt and 1-16% by weight.
  • % preferably 4-13% by weight molecularly bound water (water of hydration), furthermore sufficient water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio is 1
  • solid antiperspirant activated salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum zirconium salt and 1-16% by weight. %, preferably 4-13% by weight molecularly bound water (water of hydration), furthermore so much water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25 is, and so much glycine, that the glycine to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10 ,.
  • solid antiperspirant activated salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum zirconium salt and 1-16% by weight. %, preferably 4-13% by weight of molecularly bound water, furthermore sufficient water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25, and so much hydroxyalkanoic acid that the hydroxyalkanoic acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • Water-soluble calcium salts preferred for the stabilization of the antiperspirant salts are selected from calcium chloride, calcium bromide, calcium nitrate, calcium citrate, calcium formate, Calcium acetate, calcium gluconate, calcium ascorbate, calcium lactate, calcium glycinate, calcium carbonate, calcium sulfate, calcium hydroxide, and mixtures thereof.
  • Preferred amino acids for the stabilization of the antiperspirant salts are selected from glycine, alanine, leucine, isoleucine, ⁇ -alanine, valine, cysteine, serine, tryptophan, phenylalanine, methionine, ⁇ -amino-n-butanoic acid and ⁇ -amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred.
  • Preferred hydroxyalkanoic acids for the stabilization of the antiperspirant salts are selected from glycolic acid and lactic acid.
  • activated aluminum or aluminum zirconium salts such as disclosed in US 6902723, containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in one Amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably 1: 1 to 1:10, and a water-soluble strontium salt in such an amount as to provide a Sr : (Al + Zr) - weight ratio of 1: 1 - 1:28 and preferably 1: 2 - 1: 25 provide.
  • US 6902723 containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in one Amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably 1: 1
  • Particularly preferred solid antiperspirant activated salt compositions contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 - 13 wt .-% molecularly bound water, further enough so much water-soluble strontium salt that the Sr: (AI + Zr) weight ratio 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and so much amino acid the amino acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • solid antiperspirant activated salt compositions for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 to 13% by weight of molecularly bound water, furthermore sufficient water-soluble strontium salt that the Sr: (Al + Zr) weight ratio is 1: 1 to 1:28, preferably 1: 2 to 1:25, and as much glycine, the glycine to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • solid antiperspirant activated salt compositions for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 to 13% by weight of molecularly bound water, furthermore sufficient water-soluble strontium salt that the Sr: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25, and as much hydroxyalkanoic acid, the hydroxyalkanoic acid is in the (Al + Zr) weight ratio 2: 1-1: 20, preferably 1: 1-1: 10.
  • activated aluminum salts are those of the general formula Al 2 (OH) 6 . a Xa, wherein X is Cl, Br, I or NO 3 and "a" is a value of 0.3 to 5, preferably from 0.8 to 2.5 and particularly preferably 1 to 2, so that the molar ratio of Al X is 0.9: 1 to 2.1: 1, as disclosed, for example, in US 6074632.
  • These salts are generally slightly hydrated. associatively bound, typically 1 to 6 moles of water per mole of salt.
  • Particularly preferred is aluminum chlorohydrate (ie, X is Cl in the aforementioned formula) and especially 5/6 basic aluminum chlorohydrate wherein "a” is 1 such that the molar ratio of aluminum to chlorine is 1.9: 1 to 2.1: 1 ,
  • Preferred activated aluminum-zirconium salts are those which are mixtures or complexes of the aluminum salts described above with zirconium salts of the formula ZrO (OH) 2 _ pb b represent Y, wherein Y is Cl, Br, I, NO 3 or SO 4, b is a rational number from 0.8 to 2 and p is the valence of Y, as disclosed, for example, in US 6074632.
  • the zirconium salts also typically associate some hydration water associatively, typically 1 to 7 moles of water per mole of salt.
  • the zirconium salt is zirconyl hydroxychloride having the formula ZrO (OH) 2 -b Cl b , wherein b is a rational number of from 0.8 to 2, preferably from 1.0 to 1.9.
  • Preferred aluminum zirconium salts have a molar Al: Zr mole ratio of 2 to 10 and a metal: (X + Y) ratio of 0.73 to 2.1, preferably 0.9 to 1.5.
  • a particularly preferred salt is aluminum-zirconium chlorohydrate (ie, X and Y are Cl), which has a molar Al: Zr ratio of 2 to 10 and a molar metal: Cl ratio of 0.9 to 2.1.
  • the term aluminum-zirconium chlorohydrate includes the tri-, tetra-, penta- and octachlorohydrate forms.
  • the antiperspirant active ingredients can be present both in solubilized and in undissolved, suspended form.
  • the antiperspirant active ingredients are suspended in a water-immiscible carrier, it is preferred for reasons of product stability that the active ingredient particles have a number average particle size of 0.1-200 .mu.m, preferably 1-50 .mu.m, particularly preferably 3-20 .mu.m and extraordinarily preferably 5 - 10 microns have.
  • Preferred active substance particles have a volume-average particle size of 0.2-220 .mu.m, preferably 3-60 .mu.m, more preferably 4-25 .mu.m and most preferably 10-15.5 .mu.m.
  • Preferred aluminum salts and aluminum zirconium salts have a molar metal to chloride ratio of 0.9 to 2.0, preferably 1, 0 to 1, 51, more preferably 1, 1 to 1.5, most preferably 1.3 to 1, 4, up.
  • Further preferred aluminum zirconium trichlorohydrates have the empirical formula Al 4 (OH) 10 Cl 2 .Zr (OH) Cl.
  • Aluminiumzirconiumtetrachlorohydrate have the empirical formula Al 4 (OH) 10 Cl 2 ZrCl ⁇ 2nd
  • Aluminiumzirconiumpentachlorohydrate have the empirical formula AI 8 (OH) 20 CI 6 ⁇ Zr (OH) Cl.
  • Aluminiumzirconiumoctachlorohydrate have the empirical formula AI 8 (OH) 18 CI 6 ⁇ Zr (OH) Cl.
  • water of hydration is associatively bound to these salts, typically 1-6 moles of water per mole of salt, corresponding to 1-30% by weight, preferably 4-13% by weight of water of hydration.
  • the preferred aluminum zirconium chlorohydrates are associated with an amino acid to prevent polymerization of the zirconium species during manufacture.
  • Preferred stabilizing amino acids are selected from glycine, alanine, leucine, isoleucine, ⁇ -alanine, cysteine, valine, serine, tryptophan, phenylalanine, methionine, ⁇ -amino-n-butanoic acid and ⁇ -amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred.
  • the amino acid is contained in the salt in an amount of 1 to 3 moles, preferably 1 to 3 to 1.8 moles, per mole of zirconium.
  • the aforementioned aluminum-zirconium trichlorohydrates, aluminum-zirconium tetrachlorohydrates, aluminum-zirconium pentachlorohydrates and aluminum-zirconium octachlorohydrates are preferably present both as activated and unactivated as complexes with glycine.
  • Particularly preferred antiperspirant active substances are selected from activated aluminum-zirconium trichlorohydrex glycine, in particular activated aluminum-zirconium trichlorohydrex glycine with a water-free and glycine-free active substance (USP) of 69.5-88% by weight, preferably 72-85% by weight %, more preferably 77-80% by weight, in each case based on the raw material tel quel, of a molar metal: CI ratio of 0.9 to 1.5 and a molar Al: Zr ratio of 3.4. 3.8.
  • activated aluminum-zirconium trichlorohydrex glycine activated aluminum-zirconium trichlorohydrex glycine with a water-free and glycine-free active substance (USP) of 69.5-88% by weight, preferably 72-85% by weight %, more preferably 77-80% by weight, in each case based on the raw material tel quel, of a
  • antiperspirant active substances are selected from non-activated aluminum-zirconium trichlorohydrex glycines, in particular non-activated aluminum zirconium trichlorohydrex glycines with anhydrous and glycine-free active substance (USP) of 69.5-88% by weight, preferably 72 85% by weight, particularly preferably 77-80% by weight, each based on the raw material tel quel, a molar metal: CI ratio of 0.9 to 1, 5 and a molar AI: Zr ratio of 3.4 to 3.8.
  • USP anhydrous and glycine-free active substance
  • antiperspirant active substances are selected from activated aluminum-zirconium tetrachlorohydrex glycine, in particular activated aluminum-zirconium tetrachlorohydrex glycine with an anhydrous and glycine-free active substance (USP) of 72-88% by weight, preferably 77-85% by weight.
  • anhydrous and glycine-free active substance USP
  • antiperspirant active substances are selected from non-activated aluminum-zirconium tetrachlorohydrex glycine, in particular non-activated aluminum zirconium tetrachlorohydrex glycine with a water-free and glycine-free active substance (USP) of 72-88% by weight, preferably 77-85 Wt .-%, each based on the raw material tel quel, a molar metal: CI ratio of 0.9 to 1, 5 and a molar Al: Zr ratio of 3.4 to 3.8.
  • USP water-free and glycine-free active substance
  • antiperspirant active substances are selected from activated aluminum zirconium pentachlorohydrex glycine, in particular activated aluminum zirconium pentachlorohydrex glycine with a water-free and glycine-free active substance (USP) of 72-88% by weight, preferably 77-86% by weight. , particularly preferably 78-81, 5 wt .-%, each based on the raw material tel quel, a molar metal: CI ratio of 1, 51 to 2.0 and a molar Al: Zr ratio of 9.2 to 9 ,8th.
  • activated aluminum zirconium pentachlorohydrex glycine in particular activated aluminum zirconium pentachlorohydrex glycine with a water-free and glycine-free active substance (USP) of 72-88% by weight, preferably 77-86% by weight. , particularly preferably 78-81, 5 wt .-%, each based on the raw material tel quel,
  • antiperspirant active ingredients are selected from non-activated aluminum zirconium pentachlorohydrex glycine, in particular non-activated aluminum zirconium pentachlorohydrex glycine with a water-free and glycine-free active substance (USP) of 72-88 wt.%, Preferably 77-86 wt. %, more preferably 78-81.5% by weight, based in each case on the raw material tel quel, of a molar metal: CI ratio of 1.51 to 2.0 and a molar Al: Zr ratio of 9.2 - 9,8.
  • USP water-free and glycine-free active substance
  • the water of crystallization content of the aforementioned activated as well as unactivated aluminum zirconium trichlorohydrex glycine, aluminum zirconium tetrachlorohydrex glycine, aluminum zirconium pentachlorohydrex glycine and aluminum zirconium octachlorohydrex glycine is 1.5 to 20% by weight, preferably 7 to 15% by weight, respectively based on the raw material tel quel.
  • Further preferred aluminum zirconium trichlorohydrex glycines have the empirical formula [Al 4 (OH) 10 Cl 2 .Zr (OH) Cl] .NH 2 CH 2 COOH.
  • Aluminum-zirconium tetrachlorohydrex glycine have the empirical formula [Al 4 (OH) 10 Cl 2 ⁇ ZrOCl 2] ⁇ NH 2 CH 2 COOH.
  • Aluminum zirconium pentachlorohydrex glycines have the empirical formula [Al 8 (OH) 20 Cl 4 .Zr (OH) Cl] .NH 2 CH 2 COOH.
  • Aluminum Zirconiumoctachlorohydrex Glycine have the empirical formula [Al 8 (OH) 18 Cl 6 ⁇ Zr (OH) CI] ⁇ NH 2 CH 2 COOH or [Al 8 (OH) 18 Cl 6 ⁇ ZrOCl 2] ⁇ NH 2 CH 2 COOH.
  • aluminum zirconium chlorohydrate-glycine salts which are stabilized with betaine ((CH 3 ) S N + -Cl-I 2 -COO).
  • Particularly preferred corresponding compounds have a total molar (betaine + glycine) / Zr ratio of (0.1-3.0): 1, preferably (0.7-1.5): 1, and a betaine molar ratio Glycine of at least 0.001: 1 on.
  • Corresponding compounds are disclosed, for example, in US Pat. No. 7,105,691.
  • the particularly effective antiperspirant salt comprises a so-called "activated" salt, in particular one with a high HPLC peak 5-aluminum content, in particular with a peak 5 surface of at least 33%, particularly preferred at least 45%, based on the total area under peaks 2-5, as measured by HPLC of a 10% by weight aqueous solution of the active substance under conditions in which the aluminum species are resolved into at least 4 consecutive peaks (with peaks 2 - 5).
  • Preferred aluminum zirconium salts having a high HPLC peak 5-aluminum content also referred to as "E 5 AZCH" are disclosed, for example, in US 6436381 and US 6649152.
  • antiperspirant active ingredients are those aluminum zirconium salts having a high HPLC peak 5-aluminum content, which are additionally stabilized with a water-soluble strontium salt and / or with a water-soluble calcium salt.
  • Corresponding salts are disclosed, for example, in US Pat. No. 6,923,952.
  • astringent titanium salts such as disclosed in GB 2299506A.
  • the antiperspirant active compounds can be used as nonaqueous solutions or as glycolic solubilisates.
  • compositions according to the invention are characterized in that the at least one antiperspirant active ingredient is present in an amount of 5 to 40% by weight, preferably 10 to 35% by weight, more preferably 11 to 28% by weight and most preferably 12%. 20 wt .-%, based on the total weight of the water-free and ligand-free active substance (USP) in the total composition.
  • USP water-free and ligand-free active substance
  • the composition contains an astringent aluminum salt, in particular aluminum chlorohydrate, more preferably aluminum chlorohydrate with an anhydrous active substance (USP) of 72-88 wt .-%, based on the raw material tel quel.
  • an astringent aluminum salt in particular aluminum chlorohydrate, more preferably aluminum chlorohydrate with an anhydrous active substance (USP) of 72-88 wt .-%, based on the raw material tel quel.
  • Preferred non-activated aluminum chlorohydrates for example, in powder form as Micro Dry ®, Micro Dry ® Ultrafine or Micro Dry ® -323 from Summit Reheis, as Chlorhydrol ® (powder) as well as in activated form as Reach ® 101, Reach ® 103, Reach ® 501 Reheis / Summit or AACH-7171 is sold by Summit. Under the name Reach ® 301, an aluminum sesquichlorohydrate from Reheis is also offered, which is also particularly preferred.
  • Aluminum-zirconium tetrachlorohydrex-glycine complexes for example, from Summit Reheis under the name Rezal ® 36 GP, Summit AZG-369, or Summit AZG-364, or, in activated quality than Summit Reach ® AZP-908 , as powders are on the market.
  • aluminum-zirconium-pentachlorohydrex-glycine complexes which are commercially available, for example, in activated quality from Summit under the designations AAZG-3108 and AAZG-3110.
  • the antiperspirant active ingredients are in the formulations of the invention in an amount of 1 to 40 wt .-%, preferably from 3 to 15 wt .-%, based on the total mass of the preparation, d. H. Including possibly existing propellants used.
  • the proportion of antiperspirant active ingredients is preferably in the range from 10 to 20% by weight, in each case based on the total mass of the preparation.
  • Vicinal diols can also be present as antiperspirant active ingredients in the compositions according to the invention.
  • Preferred vicinal antiperspirant diols are selected from 1,2-propylene glycol, glycerol, 1,2-butylene glycol, 1,2-pentanediol, dipropylene glycol, tripropylene glycol, diglycerol and triglycerol.
  • the total amount of vicinal diols is preferably 10 to 50 wt .-%, more preferably 15 to 30 wt .-%, most preferably 15 to 25 wt .-%, each based on the total mass of the preparation.
  • compositions according to the invention may contain further antiperspirant active ingredients and / or deodorant active ingredients.
  • the silver citrate complex including water, is advantageously added to a proportion of at most 5% by weight, preferably 2% by weight, in particular 0.1 to 2% by weight, based on the total mass of the active compound mixture.
  • a preferred commercially available silver citrate complex contains a concentration of silver ions of 2280 to 2640 ppm, corresponding to 0.228 to 0.264% by weight of silver ions.
  • the preparations according to the invention preferably contain not more than 114 to 132 ppm of silver ions, particularly preferably 45.6 to 52.8 ppm of silver ions, exceptionally preferably 0.1-45.6 ppm or also very preferably 0.1-52.8 ppm of silver ions.
  • Further preferred compositions according to the invention are characterized in that silver ions in a total amount of 1-100 ppm, preferably 2-50 ppm, more preferably 5-20 ppm, most preferably 7-10 ppm, in each case based on the weight of the propellant-free composition of the invention are.
  • the active substance mixture is equal to the preparation, but if the preparation is an aerosol, the proportions refer to the active mixture without propellant gas.
  • the spray formulations of the present invention are preferably presented from standard aerosol and pen packages. In particular, they are suitable for spraying by standard antiperspirant valves and spray heads, as they help prevent clogging disadvantages. Advantage of the preparations according to the invention is thus that can be dispensed with elaborate special packaging such as powder valves. Such valves are less sensitive to clogging due to their special design or geometry by larger particles.
  • a disadvantage of the use of such powder valves is that the special form usually requires the use of adapted spray heads. This requires additional costs and a diversification of the packaging product range and thus additional logistical effort. These disadvantages are avoided according to the invention.
  • modified starch (INCI: Sodium Starch Octenylsuccinate or Modified Starch) may preferably be used as capsule material.
  • deodorant or antiperspirant compositions according to the invention are characterized in that at least one perfume component is present in encapsulated form.
  • the capsule material is water-soluble.
  • a preferred water-soluble capsule material is sodium starch octenyl succinate.
  • the perfume capsules are preferably composed of about 40% sodium starch octenyl succinate, 10% mannitol and about 50% perfume oil.
  • the amount of perfume capsules used is preferably in the range from 0.3 to 0.8% by weight, based on the total mass of the preparation. In addition, it is possible to contain 0.8-1.2% by weight of unencapsulated, that is to say free, perfume oil.
  • the cosmetic and dermatological preparations according to the invention may contain cosmetic adjuvants such as are conventionally used in such preparations, eg. As preservatives, bactericides, UV filters, antioxidants, vitamins, minerals, suspended solid particles, perfumes, substances to prevent foaming, dyes, pigments that have a coloring effect, thickeners, moisturizing and / or moisturizing substances or other common constituents of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers or silicone derivatives.
  • the compositions according to the invention be in the form of a pin, they preferably contain a lipid or wax matrix comprising at least one lipid or wax component with a melting point> 5O 0 C.
  • waxes of solid to brittle hard consistency coarse to fine crystalline, translucent to opaque, but not glassy, and melt above 50 0 C without decomposition. she are already slightly above the melting point low viscosity and show a strong temperature-dependent consistency and solubility.
  • Preference according to the invention for example, natural vegetable waxes, z. Candelilla wax, carnauba wax, Japan wax, sugarcane wax, ouricoury wax, cork wax, sunflower wax, fruit waxes such as orange waxes, lemon waxes, grapefruit wax, and animal waxes, e.g. Beeswax, shellac wax and spermaceti.
  • it may be particularly preferred to use hydrogenated or hardened waxes.
  • a wax component and chemically modified waxes especially the hard waxes, such as.
  • montan ester waxes hydrogenated jojoba waxes and Sasol waxes used.
  • Synthetic waxes which are also preferable in the invention include, for example, polyalkylene waxes and polyethylene glycol waxes, C 2 oC 4O dialkyl esters of dimer acids, C 30 - 50 alkyl and alkylaryl esters of -Alkylbienenwachs dinner as well as fatty acids.
  • a particularly preferred wax component is selected from at least one ester of a saturated monohydric C 6 -C 6 -alcohol and a saturated Cs-Cs ⁇ -monocarboxylic acid.
  • Esters of fatty acids and long-chain alcohols have been found to be particularly advantageous for the composition of the present invention because they give the antiperspirant preparation excellent sensory properties and overall high stability to the pin.
  • the esters are composed of saturated branched or unbranched monocarboxylic acids and saturated branched or unbranched monohydric alcohols.
  • esters of aromatic carboxylic acids and hydroxycarboxylic acids eg., 12-hydroxystearic acid
  • saturated branched or unbranched alcohols are used according to the invention, provided that the wax component has a melting point> 5O 0 C. It is particularly preferred to select the wax components from the group of esters of saturated branched or unbranched alkanecarboxylic acids of a chain length of 12 to 24 carbon atoms and the saturated branched or unbranched alcohols of a chain length of 16 to 50 carbon atoms, which has a melting point > 5O 0 C have.
  • the wax component C 6-36 alkyl stearates and C 8 - 38 stearate -Alkylhydroxystearoyl- C 2 o 4 o-Alkylerucate and cetearyl be advantageous.
  • the wax or the wax components have a melting point> 5O 0 C, preferably> 6O 0 C on.
  • a particularly preferred embodiment of the invention contains as wax component a C 2 oC 4O alkyl stearate.
  • This ester is known under the name Kester ® K82H or Kesterwachs ® K80H and is sold by Koster Keunen Inc.. It is the synthetic imitation of the monoester fraction of beeswax and is characterized by its hardness, oil gelability and broad compatibility with lipid components.
  • This wax can be used as a stabilizer and consistency regulator for W / O and O / W emulsions.
  • Kester wax has the advantage that it has an excellent oil gelability even at low concentrations and so does not make the pencil mass too heavy and a velvety abrasion allows.
  • a further particularly preferred embodiment of the invention contains as wax component cetearyl behenate, ie mixtures of cetyl behenate and stearyl behenate.
  • This ester is known under the name Kester ® K62 and is sold by Koster Keunen Inc..
  • lipid or wax components with a melting point> 5O 0 C are the triglycerides of saturated and optionally hydroxylated C 12 - 3 o-fatty acids such as hydrogenated triglyceride fats (hydrogenated palm oil, hydrogenated coconut oil, hydrogenated castor oil), glyceryl tribehenate (tribehenin), or glyceryl tri-12 Hydroxystearat, further synthetic full esters of fatty acids and glycols or polyols having 2 to 6 carbon atoms, as long as they have a melting point above 50 0 C, for example, preferably Ci 8 - C 36 Acid triglycerides (Syncrowax ® HGL-C).
  • the hydrogenated castor oil as a wax component available for example as a commercial product Cutina ® HR, is particularly preferred.
  • lipid or wax components with a melting point> 5O 0 C, the saturated linear C 4 - C 36 carboxylic acids, in particular myristic acid, palmitic acid, stearic acid and behenic acid, and mixtures of these compounds, for example.
  • Preferred deodorant or antiperspirant sticks according to the invention are characterized in that the lipid or wax component a) is selected from esters of a saturated, monohydric C 6 -C 6 o-alkanol and a saturated C 8 -C 36 monocarboxylic acid, in particular cetyl behenate , stearyl behenate and C 2 oC 4O alkyl stearate, glycerol triesters of saturated linear C I2 - C 30 carboxylic acids, which may be hydroxylated, candelilla wax, carnauba wax, beeswax, saturated linear C 4 - C 36 carboxylic acids and mixtures of the aforementioned substances.
  • esters of a saturated, monohydric C 6 -C 6 o-alkanol and a saturated C 8 -C 36 monocarboxylic acid in particular cetyl behenate , stearyl behenate and C 2 oC 4O alkyl stearate, gly
  • Particularly preferred lipid or wax component mixtures a) are selected from mixtures of cetyl behenate, stearyl behenate, hardened castor oil, palmitic acid and stearic acid. Further particularly preferred lipid or wax component mixtures a) are selected from mixtures of C 2 -C 4 -alkyl stearate, hardened castor oil, palmitic acid and stearic acid.
  • the lipid or wax component (s) is contained in total in amounts of 4 to 20% by weight, preferably 8 to 15% by weight, based on the total composition.
  • the ester (s) is / are a saturated monohydric C 16 -C 6 o alcohol and a saturated C 8 -C 36 monocarboxylic acid which is / are the lipid or wax component (s) Quantities of a total of 2 - 10 wt .-%, preferably 2 - 6 wt .-%, based on the total composition.
  • compositions of the present invention which are in the form of a spray or stick, preferably further contain at least one oil which is liquid at 20 ° C. and which does not constitute a perfume component and does not represent an essential oil.
  • Oils preferred according to the invention are selected from branched saturated or unsaturated fatty alcohols having 6 to 30 carbon atoms. These alcohols are often referred to as Guerbet alcohols, as they are available after the Guerbet reaction.
  • Preferred oils are alcohol Hexyldecanol (Eutanol ® G 16, Guerbitol ® T 16) Octyldodecanol (Eutanol ® G) and 2-ethylhexyl alcohol.
  • Other preferred oil components are mixtures of Guerbet alcohols and Guerbet alcohol esters, for example the commercial product Cetiol ® PGL (hexyldecanol and hexyldecyl laurate).
  • preferred oils are selected from the triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C 8 - 3 o-fatty acids.
  • Particularly suitable may be the use of natural oils, for example soybean oil, cottonseed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, corn oil, olive oil, rapeseed oil, sesame oil, thistle oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil and the like.
  • natural oils for example soybean oil, cottonseed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, corn oil, olive oil, rapeseed oil, sesame oil, thistle oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil and the like.
  • synthetic triglyceride oils in particular Capric / Caprylic triglycerides, z.
  • Myritol ® 318 Myritol ® 331 (Cognis) or Miglyol ® 812 (Hüls) with unbranched fatty acid residues and glyceryl triisostearin
  • Estol ® GTEH 3609 Uniqema
  • Myritol ® GTEH Cognis
  • diisopropyl adipate di-n-butyl adipate
  • di (2-ethylhexyl) adipate dioctyl adipate
  • particularly preferred oils are selected from the addition products of from 1 to 5 propylene oxide units onto mono- or polyhydric C 8-22 alkanols, such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, eg. B. PPG-2 myristyl ether and PPG-3 myristyl ether (Witconol APM ®).
  • mono- or polyhydric C 8-22 alkanols such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, eg. B. PPG-2 myristyl ether and PPG-3 myristyl ether (Witconol APM ®).
  • Further oil components preferred according to the invention are selected from the esters of linear or branched saturated or unsaturated fatty alcohols having 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms, which may be hydroxylated.
  • These include, hexyldecyl stearate (Eutanol ® G 16 S), hexyldecyl laurate, isodecyl neopentanoate, isononyl isononanoate, 2-ethylhexyl palmitate (Cegesoft ® C 24) and 2-ethylhexyl stearate (Cetiol ® 868).
  • butyloctanoate diisotridecyl acetate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate, ethylene glycol dioleate and dipalmitate.
  • oil components are selected from the addition products of at least 6 ethylene oxide and / or propylene oxide units of mono- or polyhydric C 3 - 22 -alkanols such as butanol, butanediol, myristyl alcohol and stearyl alcohol, eg.
  • PPG-14-butyl ether Ucon Fluid ® AP
  • PPG-9-butyl ether Breox B25 ®
  • PPG-10 butanediol Macol ® 57
  • PPG-15 stearyl ether Arlamol ® E
  • Further oil components preferred according to the invention are selected from the C 8 -C 22 -fekalcohol esters of monohydric or polyhydric C 2 -C 7 -hydroxycarboxylic acids, in particular the esters of glycolic acid, citric acid, malic acid, tartaric acid, citric acid and salicylic acid.
  • esters based on linear C 14 / -i 5 alkanols, z. B.
  • C 12 -C 5 alkyl citrate and of branched in the 2-position C- 12/13 alkanols are under the trademark Cosmacol ® by the company Nordmann, Rassmann GmbH & Co, Hamburg, refer, in particular the commercial products Cosmacol ® ESI, Cosmacol® ® EMI and Cosmacol® ® EIT.
  • oil components are selected from the symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, eg. B. Glycerincarbo- nat, dicaprylyl carbonate (Cetiol ® CC) or the esters of DE 197 56 454 A1.
  • Further preferred oil components according to the invention are selected from the esters of dimers of unsaturated C 2 -C 22 -fatty acids (dinner fatty acids) with monovalent linear, branched or cyclic C 2 -C 8 -alkanols or with polyvalent linear or branched C 2 -C 6 -alkanols. It may be extraordinarily preferred according to the invention to use mixtures of the abovementioned oils.
  • oil components preferred according to the invention are selected from silicone oils and hydrocarbon oils.
  • Silicone oils preferred according to the invention are selected from dialkyl and alkylaryl siloxanes, such as, for example, cyclopentasiloxane, cyclohexasiloxane, dimethylpolysiloxane and methylphenyl polysiloxane, but also include hexamethyldisiloxane, octamethyltrisiloxane and decamethyltetrasiloxane.
  • Further inventively preferred silicone oils are selected from volatile silicone oils which may be cyclic, such as. For example, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane and dodecamethylcyclohexasiloxane and mixtures thereof, as described for.
  • preferred natural and synthetic hydrocarbons are selected from paraffinic oils, isohexadecane, isoeicosane, polyisobutenes and polydecenes, for example, under the designation Emery ® 3004, 3006, 3010 or under the name ® Ethylflo of Albe- Marle or Nexbase ® are available from Nestle 2004G, and 1, 3-di- (2-ethylhexyl) -cyclohexane (Cetiol ® S).
  • compositions according to the invention are characterized in that the oil (s) liquid at 20 ° C. in a total amount of 0.1-80% by weight, preferably 2-20% by weight, particularly preferably 3-15% by weight, in each case based on the total weight of the composition, is / are contained.
  • Compositions which are particularly preferred according to the invention furthermore preferably contain at least one skin-cooling active substance.
  • Skin-cooling active ingredients suitable according to the invention are, for example, menthol, isopulegol and menthol derivatives, eg.
  • Preferred skin-cooling active ingredients are menthol, isopulegol, menthyl citrate, menthoxypropanediol and menthylpyrrolidonecarboxylic acid and mixtures of these substances, in particular mixtures of menthol and menthyl citrate, menthol, menthol glycolate and menthyl citrate, menthol and menthoxypropanediol or menthol and isopulegol.
  • At least one skin-cooling active ingredient is present in a total amount of 0.01-1% by weight, more preferably 0.02-0.5% by weight and most preferably 0.05-0.2% by weight. %, in each case based on the total weight of the composition.
  • compositions according to the invention which are formulated as a propellant-driven aerosol, contain at least one propellant.
  • propellants are propane, propene, n-butane, isobutane, isobutene, n-pentane, pentene, isopentane, isopentene, methane, ethane, dimethyl ether, nitrogen, air, oxygen, nitrous oxide, 1, 1, 1, 3-tetrafluoroethane, heptafluoro-n-propane, perfluoroethane, monochlorodifluoromethane, 1, 1-difluoroethane, both individually and in combination.
  • hydrophilic propellants such.
  • hydrophilic gases can be used advantageously in the context of the present invention, when the proportion of hydrophilic gases is selected low and lipophilic propellant gas (eg., Propane / butane) is present in excess.
  • propellant gas eg., Propane / butane
  • propane, n-butane, isobutane and mixtures of these propellants propane, n-butane, isobutane and mixtures of these propellants. It has been found that the use of n-butane as the only propellant gas according to the invention can be particularly preferred.
  • the amount of the blowing agent is preferably 20-80% by weight, more preferably 30-70% by weight and most preferably 40-50% by weight, in each case based on the total weight of the preparation, consisting of the composition according to the invention and the blowing agent .
  • pressure gas container come vessels made of metal (aluminum, tinplate, tin), protected or non-splitterndem plastic or glass, which is coated with plastic outside, in question, in their selection pressure and fracture resistance, corrosion resistance, easy fillability as well as aesthetic Aspects, handiness, printability etc. play a role.
  • Special internal protective lacquers ensure the corrosion resistance compared with the composition according to the invention.
  • compositions according to the invention also comprise at least one water-soluble polyhydric C 2 -C 9 -alkanol having 2-6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3-20 ethylene oxide units and mixtures thereof.
  • These components are preferably selected from 1,2-propylene glycol, 2-methyl-1,3-propanediol, glycerol, butylene glycols such as 1,2-butylene glycol, 1,3-butylene glycol and 1,4-butylene glycol, pentylene glycols such as 1,2.
  • Pentanediol and 1,5-pentanediol such as 1,6-hexanediol, hexanetriols such as 1, 2,6-hexanetriol, 1,2-octanediol, 1,8-octanediol, dipropylene glycol, tripropylene glycol, diglycerol, triglycerol, erythritol, Sorbitol and mixtures of the aforementioned substances.
  • Suitable water-soluble polyethylene glycols are selected from PEG-3, PEG-4, PEG-6, PEG-7, PEG-8, PEG-9, PEG-10, PEG-12, PEG-14, PEG-16, PEG-18 and PEG-20 and mixtures thereof, with PEG-3 to PEG-8 being preferred.
  • Preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one water-soluble polyhydric C 2 -C 9 -alkanol having 2 to 6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3 to 20 ethylene oxide units is selected from 1, 2 Propylene glycol, 2-methyl-1,3-propanediol, glycerin, butylene glycols such as 1,2-butylene glycol, 1,3-butylene glycol and 1,4-butylene glycol, pentylene glycols such as 1,2-pentanediol and 1,5-pentanediol, hexanediols such as 1, 6-hexanediol, hexanetriols such as 1, 2,6-hexanetriol, 1, 2-octanediol, 1, 8-octanediol, dipropylene glycol, tripropylene glycol, diglycerol
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one water-soluble polyhydric C 2 -C 9 -alkanol having 2 to 6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3 to 20 ethylene oxide units in total amounts of 3 - 30 wt .-%, preferably 8 - 25 wt .-%, particularly preferably 10-18 wt .-%, each based on the total composition, is included.
  • deodorant or antiperspirant compositions are characterized in that at least one lipid or wax component with a melting point in the range of 25 - ⁇ 5O 0 C, selected from Kokosfett Textreglycerinmono- mono-, di- and triesters, Butyrospermum Parkii (Shea Butter ) and esters of saturated, monohydric C 8 -C 18 alcohols with saturated C 12 -C 18 monocarboxylic acids and mixtures of these substances.
  • These lower melting lipid or wax components allow consistency optimization of stick-shaped or creamy products and minimization of visible residue on the skin.
  • Cocoglycerides in particular the commercial products Novata ® (ex Cognis), particularly preferably Novata AB ®, a mixture of C 2 -C 8 mono-, di- and triglycerides, which is in the range of 30 - 32 ° C to melt, and the products of Softisan series (Sasol Germany GmbH) with the INCI designation Hydrogenated Cocoglycerides, particularly Softisan 100, 133, 134, 138, 142.
  • Other preferred esters of saturated, monohydric C 2 -C 8 alcohols having saturated Ci ⁇ -C-is-monocarboxylic acids are stearyl laurate, cetearyl (z. B. Crodamol ® CSS), cetyl palmitate (eg Cutina ® CP) and myristyl myristate (eg Cetiol ® MM).
  • deodorant or antiperspirant according to the invention cooperation ratios are characterized in that with a melting point in the range of 25 at least one lipid or wax component - ⁇ 5O 0 C preferably in amounts of from 0.01 to 20 wt .-%, From 3 to 20% by weight, more preferably from 5 to 18% by weight, and most preferably from 6 to 15% by weight, based on the total composition.
  • compositions according to the invention are characterized in that they contain at least one perfume.
  • perfume oils individual fragrance compounds, e.g. the synthetic products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type are used.
  • the phenolic fragrance compounds include z. B. carvacrol. Fragrance compounds of the ester type are known e.g.
  • the ethers include, for example, benzyl ethyl ether, to the aldehydes e.g. the linear alkanals having 8 to 18 C atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamen aldehyde, hydroxycitronellal, lilial and bourgeonal, to the ketones, e.g.
  • 6-acetyl-1,1,1,4,4,6-hexamethyltetrahydronaphthalene para-t-amylcyclohexanone, 2-n-heptylcyclopentanone, ⁇ -methylnaphthyl ketone and the ionones ⁇ -isomethyl-ionone and methyl cedryl ketone, to the alcohols cinnamyl alcohol, anethole , Citronellol, Dimyrcetol, Eugenol, Geraniol, Linalool, Phenylethylalcohol and Terpineol, the hydrocarbons include 1.SA ⁇ J. ⁇ -Hexahydro ⁇ ⁇ . ⁇ J. ⁇ . ⁇ -hexamethylcyclopenta-a ⁇ -benzopyran, hydroxymethylisopropylcyclopentane, 3-a- Methyldodecahydro-6,6,9a-trimethylnaphtho-2 (2,1-b) furan, is
  • Suitable perfume oils may also contain natural fragrance mixtures, such as those obtainable from vegetable or animal sources, for example pine, citrus, jasmine, rose, lily or ylang-ylang oil.
  • essential oils of lower volatility which are mostly used as aroma components, are suitable as perfume oils, eg sage oil, chamomile oil, lemon balm oil, mint oil, cinnamon oil, lime blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, laudanum oil, clove oil, iso-eugenol, thyme oil, bergamot oil , Geranium oil and rose oil.
  • compositions according to the invention are characterized in that at least one perfume in a total amount of 0.1 to 10 wt .-%, preferably 0.2 to 7 wt .-%, particularly preferably 0.4 to 6 wt .-%, most preferably 1 to 5% by weight, furthermore very preferably 2 to 4% by weight, in each case based on the total weight of the blowing agent-free composition.
  • compositions according to the invention are silica, silica dimethyl silylates, aluminum chlorohydrate, perfume and silver citrate, advantageously as aerosol and advantageously with butane and / or propane as propellant gases.
  • a further subject of the present application is a non-therapeutic, cosmetic method for reducing and / or regulating perspiration and / or body odor, in which a composition according to the invention or a preferred composition according to the invention, in particular a composition according to one of claims 1, 2, 3 , 4, 5, 6, 7, 8, 9, 10, 11 or 12 are applied in an effective amount to the skin, preferably to the skin in the underarm area.
  • a further subject of the present application is the non-therapeutic, cosmetic use of a preferred or an inventively preferred antiperspirant composition according to the invention, in particular a composition according to one of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12 to reduce and / or regulate perspiration and / or body odor.
  • compositions according to the invention applies mutatis mutandis.
  • propellant gas preferably butane / isobutane / propane and filling ratio 5:95 to 30:70, preferably 10:90 to 20:80, preferably 15:85.
  • Compositions Nos. 1 to 8 of the invention were applied to the skin in the underarm area.
  • AZCH powder (Aluminum Zirconium 24.00 Chlorohydrate)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne une préparation cosmétique ou dermatologique non aqueuse qui contient un ou plusieurs complexes d'acide citrique et de citrate d'argent de formule (I), où x+y = 3, présentant une teneur en eau allant jusqu'à 90 % en poids, par rapport à la masse totale du complexe, en association avec un ou plusieurs agents de passivation sélectionnés dans le groupe des acides siliciques, un ou plusieurs actifs anti-transpirants et un parfum, ladite préparation étant caractérisée en ce que le ou les phyllosilicates sont contenus en quantité totale de 0 à 1,3 % en poids maximum.
PCT/EP2010/057210 2009-06-19 2010-05-26 Compositions anti-transpirantes contenant du citrate d'argent WO2010145922A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102009027052.3 2009-06-19
DE102009027052A DE102009027052A1 (de) 2009-06-19 2009-06-19 Schweißhemmende Zusammensetzungen mit Silbercitrat

Publications (2)

Publication Number Publication Date
WO2010145922A2 true WO2010145922A2 (fr) 2010-12-23
WO2010145922A3 WO2010145922A3 (fr) 2011-12-08

Family

ID=43082828

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2010/057210 WO2010145922A2 (fr) 2009-06-19 2010-05-26 Compositions anti-transpirantes contenant du citrate d'argent

Country Status (2)

Country Link
DE (1) DE102009027052A1 (fr)
WO (1) WO2010145922A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2752115A1 (fr) * 2011-09-01 2014-07-09 Taiki Corp., Ltd. Procédé de production d'un liquide antibactérien à base d'ions argent, liquide antibactérien à base d'ions argent produit par ledit procédé, procédé de production d'une poudre antibactérienne à base d'ions argent et poudre antibactérienne à base d'ions argent produite par ledit procédé
US20170151153A1 (en) * 2015-12-01 2017-06-01 Henkel Ag & Co. Kgaa Powerful hair treatment agent with anti-washout effect

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102013220771A1 (de) * 2013-10-15 2015-04-16 Henkel Ag & Co. Kgaa Schweißhemmende kosmetische Mittel mit Polycarbonsäuren

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0595339A2 (fr) * 1992-10-29 1994-05-04 The Gillette Company Composition antiperspirante pour aérosol efficacité
US20030113282A1 (en) * 2001-12-12 2003-06-19 Thitiwan Buranachokpaisan Low residue anhydrous antiperspirant stick composition
DE202008014407U1 (de) * 2008-07-08 2009-02-05 Beiersdorf Ag Kosmetische Zubereitungen mit passiviertem Silber

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2571030A (en) 1950-03-15 1951-10-09 Reheis Company Inc Astringent, antiperspirant, and method of making
US3904741A (en) 1970-10-26 1975-09-09 Armour Pharma Alcohol soluble basic aluminum chlorides and method of making same
CA958338A (en) 1971-03-08 1974-11-26 Chung T. Shin Antiperspirant powder aerosol compositions containing aluminum chloride and water soluble aluminum compounds and methods of preparation
US3887692A (en) 1972-07-10 1975-06-03 Armour Pharma Microspherical basic aluminum halides and method of making same
US4017599A (en) 1973-11-23 1977-04-12 Armour Pharmaceutical Company Aluminum-zirconium anti-perspirant systems with salts of amino acids
FR2259587A1 (en) 1974-02-04 1975-08-29 Procter & Gamble Zirconium or hafnium oxyhalide anti-perspirant cpds - used in compsns with aluminium cpds and amino acids
US4359456A (en) 1976-01-14 1982-11-16 Lever Brothers Company Antiperspirant activity of basic aluminum compounds
GB2048229A (en) 1979-04-20 1980-12-10 Gillette Co Aluminium Chlorhydroxide and Preparation Thereof
US4775528A (en) 1983-08-16 1988-10-04 The Gillette Company Antiperspirant composition
US5643558A (en) 1994-11-02 1997-07-01 The Gillette Company Method of making polyhydric alcohol solutions of enhanced efficacy antiperspirant actives
GB2299506B (en) 1995-04-03 1999-04-14 Unilever Plc Antiperspirant actives and compositions
US6010688A (en) 1997-06-25 2000-01-04 The Gillette Company Polyhydric alcohol stabilized antiperspirant salt solutions
DE69838817T3 (de) 1997-10-10 2012-07-05 Pure Bioscience Desinfektionsmittel und verfahren zu dessen herstellung
DE19756454C1 (de) 1997-12-18 1999-06-17 Henkel Kgaa Verwendung von Glycerincarbonat
US6042816A (en) 1998-08-19 2000-03-28 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
US6436381B1 (en) 2000-10-25 2002-08-20 The Gillette Company Aluminum-zirconium antiperspirant salts with high peak 5 al content
US6663854B1 (en) 2002-06-19 2003-12-16 Yan-Fei Shen Aluminum-zirconium antiperspirant salts made with zirconium salts having low Zr:Cl ratio
US6835373B2 (en) 2002-07-12 2004-12-28 The Procter & Gamble Company Non-irritating antiperspirant compositions containing acidic antiperspirant active
US7105691B2 (en) 2003-06-26 2006-09-12 Colgate-Palmolive Company Aluminum / zirconium / glycine antiperspirant actives stabilized with Betaine
US6902723B2 (en) 2003-08-14 2005-06-07 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium
US6923952B2 (en) 2003-08-14 2005-08-02 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium or calcium
US20060115440A1 (en) 2004-09-07 2006-06-01 Arata Andrew B Silver dihydrogen citrate compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0595339A2 (fr) * 1992-10-29 1994-05-04 The Gillette Company Composition antiperspirante pour aérosol efficacité
US20030113282A1 (en) * 2001-12-12 2003-06-19 Thitiwan Buranachokpaisan Low residue anhydrous antiperspirant stick composition
DE202008014407U1 (de) * 2008-07-08 2009-02-05 Beiersdorf Ag Kosmetische Zubereitungen mit passiviertem Silber

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GNPD [Online] Mintel; Juni 2008 (2008-06), "Deodorant Stick", XP002646050, Database accession no. 931584 *
HASENZAHL S ET AL: "Fumed silica for personal care and cosmetics-versatile and effective", SOFW-JOURNAL SEIFEN, OELE, FETTE, WACHSE, VERLAG FUR CHEMISCHE INDUSTRIE, AUGSBURG, DE, Bd. 129, Nr. 8, 1. Januar 2003 (2003-01-01), Seiten 22-24,26,28,, XP001539786, ISSN: 0942-7694 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2752115A1 (fr) * 2011-09-01 2014-07-09 Taiki Corp., Ltd. Procédé de production d'un liquide antibactérien à base d'ions argent, liquide antibactérien à base d'ions argent produit par ledit procédé, procédé de production d'une poudre antibactérienne à base d'ions argent et poudre antibactérienne à base d'ions argent produite par ledit procédé
CN103945690A (zh) * 2011-09-01 2014-07-23 株式会社黛怡茜 银离子抗菌液的生成方法、用该方法生成的银离子抗菌液或银离子抗菌粉末的生成方法、用该方法生成的银离子抗菌粉末
EP2752115A4 (fr) * 2011-09-01 2015-03-11 Taiki Corp Ltd Procédé de production d'un liquide antibactérien à base d'ions argent, liquide antibactérien à base d'ions argent produit par ledit procédé, procédé de production d'une poudre antibactérienne à base d'ions argent et poudre antibactérienne à base d'ions argent produite par ledit procédé
US10806149B2 (en) 2011-09-01 2020-10-20 Taiki Corp., Ltd. Method for producing silver-ion antibacterial liquid, silver-ion antibacterial liquid produced by said method, method for producing silver-ion antibacterial powder, and silver-ion antibacterial powder produced by said method
US20170151153A1 (en) * 2015-12-01 2017-06-01 Henkel Ag & Co. Kgaa Powerful hair treatment agent with anti-washout effect
US10945941B2 (en) * 2015-12-01 2021-03-16 Henkel Ag & Co. Kgaa Powerful hair treatment agent with anti-washout effect

Also Published As

Publication number Publication date
WO2010145922A3 (fr) 2011-12-08
DE102009027052A1 (de) 2010-12-23

Similar Documents

Publication Publication Date Title
EP2451426A2 (fr) Compositions cosmétiques contenant des suspensions de sels d'argent
DE102010063250A1 (de) Wasserhaltige Antitranspirant-Zusammensetzungen mit verbesserter Rückstandsmaskierung
DE102011083293A1 (de) Wasserfreie Formulierungen mit kühlender Wirkung
DE102009002097A1 (de) Antitranspirant-Sprays mit Esterölen
EP2665463B1 (fr) Stick antitranspirant ayant une meilleure stabilité à long terme
EP2480192B1 (fr) Anti-transpirants non aérosol sans eau à libération améliorée d'agents
DE102011083872A1 (de) Wasserfreie Kosmetika mit einem natürlichen Feuchtigkeitsabsorber
WO2010145923A2 (fr) Sprays anti-transpirants
DE102017223179B4 (de) Rückstandsminimierte schweißhemmende Zusammensetzung mit verbessertem Hautgefühl
EP3057665A1 (fr) Agent cosmétique anti-transpiration contenant des lactates
WO2010145921A2 (fr) Compositions cosmétiques contenant des sels d'argent sélectionnés
EP2442780B1 (fr) Compositions cosmétiques contenant du lactate d'argent
DE102009055255A1 (de) Wasserfreie Antitranspirant-Sprays mit verbesserter Leistung
WO2010145922A2 (fr) Compositions anti-transpirantes contenant du citrate d'argent
WO2014187576A1 (fr) Association de principes actifs désodorisante
DE102011088967A1 (de) Deodorants und Antitranspirants mit stabilisiertem Antioxidans
WO2015055195A1 (fr) Produit cosmétique anti-transpirant contenant des acides amidosulfoniques
WO2015055198A1 (fr) Agent cosmétique anti-transpiration contenant des acides sulfoniques aromatiques
DE102015224559B4 (de) "Textil schonende Antitranspirant-Zusammensetzungen"
EP3057568B1 (fr) Utilisation de l'acide méthanesulfonique et de ses sels pour l'activation et/ou stabilisation des sels d'aluminium anti-transpirants
EP2442781B1 (fr) Compositions cosmétiques contenant du sulfate d'argent
WO2015055196A2 (fr) Agent cosmétique anti-transpirant comprenant des acides polycarboxyliques
DE102011087980A1 (de) Deodorants und Antitranspirants mit Haar aufhellender Wirkung
EP3057567A2 (fr) Produits cosmétiques anti-transpirants aux alpha-hydroxyacides

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10722071

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10722071

Country of ref document: EP

Kind code of ref document: A2